Igor Kos

4PUBLICATIONS

11CO-AUTHORS

Molecular targetsGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Bioprocessing, bioproduction and bioproducts

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|May 21, 2026

Plasmacytic markers as immunotherapeutic targets for primary CD20-negative aggressive B-cell lymphomas.

|Apr 18, 2025

A German multicenter real-world analysis of talquetamab in 138 patients with relapsed/refractory multiple myeloma.

Jan H Frenking, Christine Riedhammer, Raphael Teipel

|Mar 31, 2021

Increased B-cell activity with consumption of activated monocytes in severe COVID-19 patients.

Igor Kos, Benedikt Balensiefer, Vadim Lesan

|Sep 20, 2018

Partnership for productive development of biosimilar products: perspectives of access to biological products in the Brazilian market.

Morton Aaron Scheinberg, Paulo Antonio Oldani Felix, Igor Age Kos

Pageof 1

Frequent Collaborators

Moritz Bewarder

Onur Cetin

Eva C Schwarz

Lorenz Thurner

Morton Aaron Scheinberg

1 joint publications

Paulo Antonio Oldani Felix

1 joint publications

Maurício De Angelo Andrade

1 joint publications

Valderilio Feijó Azevedo

1 joint publications

Jan H Frenking

1 joint publications

Christine Hanoun

Frequent Collaborators

Moritz Bewarder

Onur Cetin

Eva C Schwarz

Lorenz Thurner